Liquidia Corp Ordinary Shares (NASDAQ:LQDA)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - LQDA
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - LQDA
- Market Cap$132.070m
- SymbolNASDAQ:LQDA
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS53635D2027
Company Profile
Liquidia Corp, formerly Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain.
Latest LQDA news
Currently there for this company. Visit our news hub for other news .